Bydureon Weight Loss

£168.00£297.00

Bydureon (Exenatide extended-release) is a medication used to treat type 2 diabetes. It belongs to the class of GLP-1 receptor agonists. Unlike short-acting exenatide formulations, Bydureon is administered once weekly via subcutaneous injection. This extended-release formulation provides sustained therapeutic levels of exenatide, enhancing patient convenience and compliance.

SKU: N/A Category: